EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Targeting Cellular Senescence: A New Therapeutic Axis in Chronic Liver Disease

Jiarui Li, Ze Xiang, Yunyang Xu, Xingyu Luo, Yao Jiang, Yingchen Huang, Zhe Yang, Ronggao Chen, Xiao Xu

Engineering · 2026-03

DOI: 10.1016/j.eng.2026.02.019 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Engineering, 2026-03. Verfasst von Jiarui Li und 8 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 237 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Fundamental Research Funds for the Central Universities, National Natural Science Foundation of China, Key Research and Development Program of Zhejiang Province.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Förderung

  • Fundamental Research Funds for the Central Universities
  • National Natural Science Foundation of China
  • Key Research and Development Program of Zhejiang Province
  • National Key Research and Development Program of China

Zitieren

APA

Li, J., Xiang, Z., Xu, Y., Luo, X., Jiang, Y., Huang, Y., Yang, Z., Chen, R., & Xu, X. (2026). Targeting Cellular Senescence: A New Therapeutic Axis in Chronic Liver Disease. Engineering. https://doi.org/10.1016/j.eng.2026.02.019

Vancouver

Li J, Xiang Z, Xu Y, Luo X, Jiang Y, Huang Y, et al. Targeting Cellular Senescence: A New Therapeutic Axis in Chronic Liver Disease. Engineering. 2026. doi:10.1016/j.eng.2026.02.019

BibTeX
@article{Li2026,
  author = {Li, Jiarui and Xiang, Ze and Xu, Yunyang and Luo, Xingyu and Jiang, Yao and Huang, Yingchen and Yang, Zhe and Chen, Ronggao and Xu, Xiao},
  title = {Targeting Cellular Senescence: A New Therapeutic Axis in Chronic Liver Disease},
  journal = {Engineering},
  year = {2026},
  doi = {10.1016/j.eng.2026.02.019}
}
Kostenlos starten →